S P Juraschek1, E R Miller1, L J Appel1, R H Christenson2, F M Sacks3, E Selvin1. 1. Johns Hopkins School of Medicine, Johns Hopkins Bloomberg School of Public Health, and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD. 2. University of Maryland School of Medicine. 3. Harvard T.H. Chan School of Public Health, Harvard Medical School, Brigham & Women's Hospital, Boston, MA, USA.
Abstract
AIMS: To determine the effects of dietary changes in amount and type of carbohydrate on 1,5-anhydroglucitol levels. METHODS: We conducted an ancillary study to a completed, randomized clinical trial in overweight and obese adults without diabetes (N=159). Using a crossover design, participants were fed each one of four diets in turn for 5 weeks, with 2-week washout periods inbetween. The four diets were: high glycaemic index (≥65) with high proportion of carbohydrate (58% kcal) (GC); low glycaemic index (GI≤45) with low proportion of carbohydrate (40% kcal) (gc); low glycaemic index with high proportion of carbohydrate (gC); and high glycaemic index with low proportion of carbohydrate (Gc). Plasma 1,5-anhydroglucitol levels were measured at baseline and after each feeding period. RESULTS: At baseline, participants had a mean age of 53 years (53% women, 52% non-Hispanic black, 50% obese). Their mean fasting glucose and 1,5-anhydroglucitol levels were 97 mg/dl (5.4 mmol/l) and 18.6 μg/mL (113.3 μmol/l), respectively. Compared with baseline, each of the four diets reduced 1,5-anhydroglucitol by a range of -2.4 to -3.7 μg/mL (-14.6 to -22.5 μmol/l); all P <0.001). Reducing either glycaemic index or proportion of carbohydrate lowered 1,5-anhydroglucitol levels. These effects were additive, such that reducing both glycaemic index and proportion of carbohydrates decreased 1,5-anhydroglucitol by -1.31 μg/mL [95% CI: -1.63, -0.99; P<0.001 or -8.0 (-9.9, -6.0) μmol/l]. Furthermore, these effects were confirmed in a subgroup of participants with 12-h glucose monitoring and no documented hyperglycaemia (fasting glucose <160 mg/dl or 8.9 mmol/l). CONCLUSIONS: Both type and amount of dietary carbohydrate affect 1,5-anhydroglucitol plasma concentrations in adults without diabetes. This finding contradicts the long-standing notion that 1,5-anhydroglucitol remains at constant concentrations in the blood in the absence of hyperglycaemic excursions. (Clinical trials registry number: NCT00051350).
RCT Entities:
AIMS: To determine the effects of dietary changes in amount and type of carbohydrate on 1,5-anhydroglucitol levels. METHODS: We conducted an ancillary study to a completed, randomized clinical trial in overweight and obese adults without diabetes (N=159). Using a crossover design, participants were fed each one of four diets in turn for 5 weeks, with 2-week washout periods inbetween. The four diets were: high glycaemic index (≥65) with high proportion of carbohydrate (58% kcal) (GC); low glycaemic index (GI≤45) with low proportion of carbohydrate (40% kcal) (gc); low glycaemic index with high proportion of carbohydrate (gC); and high glycaemic index with low proportion of carbohydrate (Gc). Plasma 1,5-anhydroglucitol levels were measured at baseline and after each feeding period. RESULTS: At baseline, participants had a mean age of 53 years (53% women, 52% non-Hispanic black, 50% obese). Their mean fasting glucose and 1,5-anhydroglucitol levels were 97 mg/dl (5.4 mmol/l) and 18.6 μg/mL (113.3 μmol/l), respectively. Compared with baseline, each of the four diets reduced 1,5-anhydroglucitol by a range of -2.4 to -3.7 μg/mL (-14.6 to -22.5 μmol/l); all P <0.001). Reducing either glycaemic index or proportion of carbohydrate lowered 1,5-anhydroglucitol levels. These effects were additive, such that reducing both glycaemic index and proportion of carbohydrates decreased 1,5-anhydroglucitol by -1.31 μg/mL [95% CI: -1.63, -0.99; P<0.001 or -8.0 (-9.9, -6.0) μmol/l]. Furthermore, these effects were confirmed in a subgroup of participants with 12-h glucose monitoring and no documented hyperglycaemia (fasting glucose <160 mg/dl or 8.9 mmol/l). CONCLUSIONS: Both type and amount of dietary carbohydrate affect 1,5-anhydroglucitol plasma concentrations in adults without diabetes. This finding contradicts the long-standing notion that 1,5-anhydroglucitol remains at constant concentrations in the blood in the absence of hyperglycaemic excursions. (Clinical trials registry number: NCT00051350).
Authors: Kathleen M Dungan; John B Buse; Joseph Largay; Mary M Kelly; Eric A Button; Shuhei Kato; Steven Wittlin Journal: Diabetes Care Date: 2006-06 Impact factor: 19.112
Authors: W J Kim; C Y Park; S E Park; E J Rhee; W Y Lee; K W Oh; S W Park; S W Kim; H S Park; Y J Kim; S J Song; H Y Ahn Journal: Diabet Med Date: 2012-09 Impact factor: 4.359
Authors: Y Fukumura; S Tajima; S Oshitani; Y Ushijima; I Kobayashi; F Hara; S Yamamoto; M Yabuuchi Journal: Clin Chem Date: 1994-11 Impact factor: 8.327
Authors: Elizabeth Selvin; Lesley M A Francis; Christie M Ballantyne; Ron C Hoogeveen; Josef Coresh; Frederick L Brancati; Michael W Steffes Journal: Diabetes Care Date: 2011-02-18 Impact factor: 19.112
Authors: Meghana D Gadgil; Lawrence J Appel; Edwina Yeung; Cheryl A M Anderson; Frank M Sacks; Edgar R Miller Journal: Diabetes Care Date: 2012-12-05 Impact factor: 19.112
Authors: Cara B Ebbeling; Gloria L Klein; Patricia K Luoto; Julia M W Wong; Lisa Bielak; Ralph G Eddy; Sarah K Steltz; Courtenay Devlin; Megan Sandman; Bridget Hron; Kim Shimy; Steven B Heymsfield; Robert R Wolfe; William W Wong; Henry A Feldman; David S Ludwig Journal: Contemp Clin Trials Date: 2017-12-09 Impact factor: 2.226
Authors: Bethany Warren; Alexandra K Lee; Christie M Ballantyne; Ron C Hoogeveen; James S Pankow; Morgan Grams; Anna Köttgen; Elizabeth Selvin Journal: Clin Chem Date: 2018-08-07 Impact factor: 8.327
Authors: Edith Feskens; Lorraine Brennan; Pierre Dussort; Matthieu Flourakis; Lena M E Lindner; David Mela; Naila Rabbani; Wolfgang Rathmann; Frédérique Respondek; Coen Stehouwer; Stephan Theis; Paul Thornalley; Sophie Vinoy Journal: Adv Nutr Date: 2020-09-01 Impact factor: 8.701
Authors: Ledibabari M Ngaage; Emmanuel N Osadebey; Sebastian T E Tullie; Adekunle Elegbede; Erin M Rada; Elias K Spanakis; Nelson Goldberg; Sheri Slezak; Yvonne M Rasko Journal: Plast Reconstr Surg Glob Open Date: 2019-05-16
Authors: Susan A Masino; David N Ruskin; Natalie R Freedgood; Marie Lindefeldt; Maria Dahlin Journal: Nutr Metab (Lond) Date: 2021-03-01 Impact factor: 4.169
Authors: Jiun-Ruey Hu; Yingfei Wu; Frank M Sacks; Lawrence J Appel; Edgar R Miller Iii; J Hunter Young; Stephen P Juraschek Journal: BMJ Open Diabetes Res Care Date: 2020-08